It’s been a turbulent few days for the biotech sector with the NASDAQ Biotechnology Index declining 5.46% over the last five trading days. A major part of this decline was recorded on Monday as the sector reacted to negative pipeline updates from companies like Amgen (AMGN – Analyst Report) and Celladon (CLDN – Snapshot Report). Meanwhile, Biogen’s (BIIB – Analyst […]
By Ben LevisohnIt’s that time of the year, when biotech stocks are tumbling–Amgen (AMGN), Celgene (CELG) and Biogen Idec (BIIB) are all down about 3%–and investors looking at the iShares NASDAQ Biotechnology ETF (IBB) and wondering if this is the end of the sector’s astounding run.
Bloomberg News
The answer: Who knows? There’s certainly little in the way of news that would cause […]
by Tony BoydJust when Australia’s beaten-down biotech sector was in need of a boost, Silviu Itescu at stem cell pioneer Mesoblast sends positive signals by selling $58.5 million in stock to US pharmaceutical giant, Celgene Corporation.This is a hugely important transaction for Mesoblast and the Australian biotech sector. It shows big pharma is not content to sit back and rely on […]
Source: “11g poker chips” by Logan Ingalls from South Boston, MA, USA. Licensed under CC BY 2.0 via Wikimedia CommonsGive up now if you’re looking for a totally safe biotech stock. They don’t exist.But if you’re looking for a biotech stock that is relatively safe compared to most others, that’s a different story. And there’s one biotech that is arguably the […]
Biotech bubble may just be an optical illusion
By iCELL News on March 27, 2015 · Sector
SAN FRANCISCO (MarketWatch)—The stellar performance of biotechnology stocks in the past few years has predictably sparked fears of an impending crash. But for all the talk of a bubble, biotechs are far from being overbought, according to analysts at Credit Suisse.“There are optics suggesting that […]
Related CELGIs It Closing Time At The Biotech Bar?Weekly Options Outlook: Bulls Leave Money On The Table Despite A Week-End WinCelgene backs away from development of mAb for blood cancer(Seeking Alpha)Related ILMNIs It Closing Time At The Biotech Bar?3 Niche ETFs Breaking Out3 Excellent Biotech Stocks to Buy on the Dip – Stocks in the News(Zacks)By and large, the short […]
View photo.By and large, the short interest moves in the leading biotechs and emerging pharmaceuticals were mild between the February 27 and March 13 settlement dates. However, Celgene Corporation (NASDAQ: CELG), Illumina, Inc. (NASDAQ: ILMN) and Medivation Inc (NASDAQ: MDVN) saw double-digit percentage upswings in their short interest.Here we take a quick look at how these three stocks have fared […]
Investing.com – Investing.com — Stocks on U.S. equities markets fell slightly amid a weakening dollar, as late losses on Monday afternoon erased previous gains in morning trading.The Dow Jones Industrial Average dropped 11.61 points or 0.06% to 18,116.04, while the NASDAQ Composite index retreated from near record highs at the end of trading last week. The S&P 500 also fell […]
The biotech sector has been on a roll lately. The SPDR S&P Biotech ETF ; ;has more than tripled since the start of 2012, compared to “just” a 63% increase in the S&P 500 .Source: Jeff Kubina via Flickr .Are we in a bubble that’s about to pop? We’ll only know for sure if (when?) the sector pulls back.In the […]
Seymour warned that the fund sat in “overbought territory,” saying that it might soon pull back. Trader Brian Kelly agreed, adding that investors might want to take profits on biotech names next week.Some biotech names may not have exhausted their momentum, trader Guy Adami said. He believes that Celgene could move even higher, adding that Gilead and Amgen may have […]
